US

Ugra Sen Singh

Active Director Director DIN 11255914
DIN 11255914 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ugra Sen Singh

Data last updated:

Ugra Sen Singh is a Director at Neelshant Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11255914
Primary Designation Director
Industry Pharma
First Appointment 22 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20252025Active

Board colleagues of Ugra Sen Singh

NameDINCompanyDesignation
Sandhya Singh11255915Neelshant Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neelshant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ugra Sen Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ugra Sen Singh

Ugra Sen Singh currently holds 1 directorship: Neelshant Pharmaceuticals Private Limited (Director, since 22 Aug 2025).

Ugra Sen Singh was first appointed on 22 Aug 2025 as Director at Neelshant Pharmaceuticals Private Limited.

The current boards of Ugra Sen Singh's companies include Sandhya Singh (Neelshant Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available